MedPath

Parent-Adolescent Training on Neurofeedback and Synchrony

Not Applicable
Completed
Conditions
Testing Protocol With Healthy Individuals for Feasibility
Interventions
Behavioral: Real-time fMRI neurofeedback
Registration Number
NCT03929263
Lead Sponsor
Oklahoma State University Center for Health Sciences
Brief Summary

The study will test a real-time functional magnetic resonance imaging (fMRI) hyperscanning neurofeedback protocol for feasibility with ten mothers and their psychiatrically healthy adolescent daughters, with the eventual goal to test this in a sample of depressed adolescents in a future study.

Detailed Description

This study will utilize a rigorous multi-method, multi-informant design to examine the effects of dyadic neurofeedback (dnf) on adolescent brain activation with fMRI hyperscanning. Parents and adolescents will also report on emotion regulation, depressive symptoms, and parenting practices. Data collection procedures will take place at the Laureate Institute for Brain Research (LIBR), which is equipped with two identical scanners that have advanced real-time fMRI systems capable of conducting parallel fMRI hyperscanning, including the capacity for neurofeedback. Parents will complete a phone screen to determine initial eligibility. If initial study criteria are met, a 2-hour in-person lab visit will be scheduled where mothers and daughters will complete consent/assent; diagnostic interviews; surveys on emotion regulation, parenting practices, depression, and anxiety; and additional screening. Survey data will be used for preliminary exploratory analyses. Based on data collected from the screening visit, participants will be invited to participate in the full study: a 4-hour visit where mothers and daughters will complete emotion ratings, mock scanner training, and fMRI tasks individually and together using hyperscanning (scan time = 16 min resting-state \[2 runs\], 7 min structural MRI, 40 min fMRI tasks, 10 min clinical MRI scans).

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
42
Inclusion Criteria
  • Eligible for fMRI
  • Sufficient English fluency to complete tasks
  • BMI ≦ 40.0
  • Right-handed
  • Biological female
  • Co-residing at least 4 days/week
  • Adult participants: Biological mother of adolescent participant
  • Adult participants:Primary caregiver > 50% of child's lifespan
  • Adult participants:BMI ≧ 18.0
  • Adolescent participants: Age 13-17 years
  • Adolescent participants: BMI ≧ 16.0
Exclusion Criteria
  • Current psychiatric diagnosis
  • Medications influencing fMRI
  • Medical conditions influencing fMRI
  • Alcohol or psychoactive drug on scan day
  • Adolescent participants: Neurodevelopmental delay
  • Adolescent participants: History of mood or psychotic disorder
  • Adolescent participants: History of obsessive-compulsive disorder (OCD) or attention-deficit/hyperactivity disorder (ADHD)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Real-time fMRI neurofeedbackReal-time fMRI neurofeedbackAll participants will receive neurofeedback from the target region (no sham condition).
Primary Outcome Measures
NameTimeMethod
Neurofeedback Rating ScaleBaseline (Acquired during scan session)

Rating scale of perceived effectiveness in completing the task and changing brain activation. Likert scale ranging from 0-10, with higher numbers indicating greater perceived effectiveness.

Emotion Rating ScaleBaseline (Acquired during scan session)

Rating scale asking about current experience of various emotions (happy, sad, angry, etc.). Scale ranges from 0-10, with higher numbers indicating more intense emotions.

Blood Oxygen Level-Dependent (BOLD) Signal Changes (Brain Activation)Baseline (Acquired during scan session)

Activation in the brain region targeted for neurofeedback and associated regions; resting-state network activity

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Laureate Institute for Brain Research

🇺🇸

Tulsa, Oklahoma, United States

© Copyright 2025. All Rights Reserved by MedPath